855PD - Adjuvant sunitinib (SU) in patients (pts) with high risk renal cell carcinoma (RCC): Safety and therapy management in S-TRAC trial
| Autor: | Staehler, M., Motzer, R.J., George, D.J., Pandha, H.S., Donskov, F., Escudier, B., Kliment, J., Pantuck, A.J., Patel, A., Deannuntis, L., Bhattacharyya, H., Lin, X., Lechuga, M., Serfass, L., Patard, J-J., Ravaud, A. |
|---|---|
| Zdroj: | In Annals of Oncology September 2017 28 Supplement 5:v300-v300 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|